| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 16,720 | 13 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | 13 Feb 2023 | 1 | $0 | 4 | Chief Scientific Officer | 15 Feb 2023, 15:47 |
| SAGE | Sage Therapeutics, Inc. | 03 Feb 2023 | 2 | -$49,768 | 4 | Chief Scientific Officer | 07 Feb 2023, 15:11 |
| SAGE | Sage Therapeutics, Inc. | 11 Feb 2022 | 1 | $0 | 4 | Chief Scientific Officer | 15 Feb 2022, 15:42 |
| SAGE | Sage Therapeutics, Inc. | 19 Oct 2021 | 2 | -$44,964 | 4 | Chief Scientific Officer | 21 Oct 2021, 16:03 |
| SAGE | Sage Therapeutics, Inc. | 15 Jun 2021 | 2 | -$67,267 | 4 | Chief Scientific Officer | 17 Jun 2021, 09:12 |